Arcadia Biosciences (RKDA) Return on Invested Capital (2015 - 2023)

Arcadia Biosciences (RKDA) has 9 years of Return on Invested Capital data on file, last reported at 2.05% in Q4 2023.

• Quarterly Return on Invested Capital fell 138.0% year-over-year to 2.05% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 2.05% (down 138.0% YoY) and the FY2022 annual result came in at 2.5%, down 223.0% from the prior year.
• Return on Invested Capital declined to 2.05% in Q4 2023, from 1.32% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q2 2021 to a low of 3.38% in Q2 2020.
• A 5-year average of 1.23% and a median of 1.1% in 2019 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2020 — Return on Invested Capital slumped 229 bps — and 2021, when it jumped 335 bps.
• Tracing RKDA's Return on Invested Capital over 5 years: stood at 2.1% in 2019, then surged by 95 bps to 0.11% in 2020, then tumbled by 238 bps to 0.37% in 2021, then sank by 82 bps to 0.67% in 2022, then tumbled by 207 bps to 2.05% in 2023.
• The last three Return on Invested Capital figures came in at 2.05% (Q4 2023), 1.32% (Q3 2023), and 0.92% (Q2 2023), per Business Quant data.